Home › Metastatic Cancer › NCT07195513
Electronic Patient Reporting of Symptoms and Unmet Needs to Connect Patients With Advanced Cancer to Palliative Care Services
"PRO-CONNECT" Patient-Reported Outcomes to Coordinate Supportive Care for Unmet Needs During Cancer Treatment
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria 1. Age ≥18 years. 2. Diagnosis of unresectable or metastatic, incurable thoracic, gastrointestinal, or breast solid tumor. 3. Receiving active cancer-directed therapy longitudinally in the outpatient oncology clinic and expected to continue treatment. Exclusion Criteria 1. Members of vulnerable populations, including infants, minors, individuals unable to provide informed consent, and those who are incarcerated or imprisoned at the time of enrollment. 2. Already established with palliative care, defined as having a scheduled future palliative care appointment, a pending referral, or a visit with palliative care within the past 90 days. 3. Unable to provide informed consent in English. 4. Cognitive impairment that, in the judgment of the treating clinician, would preclude study participation.
About the study
This study is testing whether electronic surveys can help patients with advanced cancer report their symptoms and care needs so their doctors can connect them to palliative/supportive care services sooner. The goal is to see if this approach can make it easier for patients to get support for symptoms, quality of life, and other needs during cancer treatment.
What is being tested
- ePRO-Directed Referral and Navigation to Palliative/Supportive Care (behavioral)
- ePRO Symptom Monitoring with Usual Palliative Care Referral (other)
Sponsor: Dartmouth-Hitchcock Medical Center · Participants: 90 · Started: Feb 25, 2026
Contact the study team
- Delaney K Reese, MS · Phone: 603-650-3784
- Loretta H Pearson, MPhil, CCRC · Phone: 603-653-3561
Official record on ClinicalTrials.gov — NCT07195513
Locations in the U.S.
| New Hampshire | Dartmouth-Hitchcock Medical Center, Lebanon |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.